The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics-Reference-Cited by-同舟云学术

The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics

Published:2022-11-25 Issue:3 Volume:16 Page:422-428
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Hishe Hailemichael Z.¹²,Stocker Sophie L.³⁴,Stamp Lisa K.⁵^ORCID,Dalbeth Nicola⁶,Merriman Tony R.⁷⁸,Phipps‐Green Amanda⁷,Wright Daniel F. B.¹^ORCID

Affiliation:

1. School of Pharmacy University of Otago Dunedin New Zealand

2. School of Pharmacy Mekelle University Mekelle Tigray Ethiopia

3. School of Pharmacy University of Sydney New South Wales Sydney Australia

4. Department of Clinical Pharmacology & Toxicology St. Vincent's Hospital Sydney Darlinghurst New South Wales Australia

5. Department of Medicine University of Otago Christchurch New Zealand

6. Department of Medicine University of Auckland Auckland New Zealand

7. Department of Biochemistry University of Otago Dunedin New Zealand

8. Division of Clinical Immunology and Rheumatology University of Alabama at Birmingham Birmingham Alabama USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13460

Reference25 articles.

1. Clinical Pharmacokinetics and Pharmacodynamics of Allopurinol and Oxypurinol

2. Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels

3. Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2

4. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone;Iwanaga T;Drug Metab Dispos,2005

5. Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in Humans

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Genome-Wide Association Study of Oxypurinol Concentrations in Patients Treated with Allopurinol;Journal of Personalized Medicine;2024-06-18

2. The impact of peritoneal dialysis on oxypurinol and urate elimination in people with gout;Nephrology;2024-04-16

3. The development and evaluation of dose‐prediction tools for allopurinol therapy (Easy‐Allo tools);British Journal of Clinical Pharmacology;2024-02-15

4. Urinary oxypurinol is a useful tool to assess adherence to allopurinol in clinical practice;Rheumatology;2024-01-10